Ticker
RLAYCompany Name
RELAY THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 116.2M | 3.57 | $ 32.52M |
3/31/2025 | $ 95.66M | 2.58 | $ 37.05M |
12/31/2024 | $ 126.41M | 2.49 | $ 50.73M |
9/30/2024 | $ 154.48M | 3.29 | $ 46.97M |
6/30/2024 | $ 136.83M | 3.04 | $ 45.04M |
3/31/2024 | $ 155.57M | 4.19 | $ 37.14M |
12/31/2023 | $ 146.44M | 4.84 | $ 30.27M |
9/30/2023 | $ 154.03M | 3.04 | $ 50.75M |
6/30/2023 | $ 148.61M | 2.08 | $ 71.58M |
3/31/2023 | $ 163.85M | 2.33 | $ 70.47M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for RELAY THERAPEUTICS INC is calculated as follows: CashnEq [ $ 560.16M ] / LiabilitesC [ $ 15.67M ]
(=) Cash Ratio [ 35.76 ]
Minimum
Jun 30, 2023
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |